Compugen (CGEN) Free Cash Flow (2009 - 2010)
Compugen's (CGEN) quarterly Free Cash Flow came in at -$919000.0 in Q4 2010, up 57.28% year-on-year from -$584324.3 in Q4 2009, and down 141.84% quarter-over-quarter from -$380000.0 in Q3 2010.
Compugen (CGEN) Free Cash Flow (2009 - 2010) Analysis & Trends
Compugen has disclosed Free Cash Flow across 2 years of filings, most recently posting -$919000.0 for Q4 2010.
- Free Cash Flow for Q4 2010 came in at -$919000.0, up 57.28% year-over-year; the trailing twelve-month figure through Sep 2011 was -$919000.0 (up 63.69% YoY), and the FY2025 annual result was $31.3 million, down 36.69% from the prior year.
- Free Cash Flow came in at -$919000.0 for Q4 2010 at Compugen, down from -$380000.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$380000.0 in Q3 2010 to a low of -$2.2 million in Q4 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | Compugen | 189.59 Mn | 97.83 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | -919,000.00 |
| Dec 31, 2010 | -919,000.00 |
| Sep 30, 2010 | -380,000.00 |
| Sep 30, 2010 | -380,000.00 |
| Dec 31, 2009 | -2.15 Mn |
| Dec 31, 2009 | -2.15 Mn |
| Sep 30, 2009 | -942,000.00 |
| Sep 30, 2009 | -942,000.00 |